Pantherna Therapeutics
pantherna-therapeutics.com
Vaccines
Biotechnology
Claim pageClaim
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
1
High-Tech Gründerfonds
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
2017
Founded
Registers and programsofficial lists and records that name the company
| Registered | 26 Oct 2017 |
Backed byfrom the funds' portfolios and accelerator catalogs
High-Tech Gründerfonds Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Inside Therapeutics is a company specialized in providing system for nanoparticle synthesis or nanoparticle manufacturing using…
Etherna pioneers in mRNA-LNP platforms, offering custom drug delivery platforms for tailored and innovative LNP drug delivery solutions.
NeoVac is creating revolutionary, unique and proprietary next-generation lipid nanoparticles.
Primrose Bio develops and commercializes manufacturing technologies that close gaps in biologics, mRNA and vaccine production.
Genvax Technologies is an animal vaccine company developing next-generation mRNA + nanoparticle vaccines from Ames, Iowa. Our mission is to…
Gamgee is developing personalised mRNA vaccines as a cancer treatment for dogs, built from each dog’s tumour. See how it works with vets…
Overview
Pantherna Therapeutics is a privately-held biopharmaceutical Company developing first-in-class therapeutics for vascular diseases. Pantherna’s innovative technology platform is based on advanced nanoparticles for the delivery and expression of therapeutic mRNA drugs in the endothelium.